Survival in melanoma brain metastases in the era of novel systemic therapies.

Neuro-oncology advances(2020)

引用 3|浏览1
暂无评分
摘要
In the setting of SACTs, survival in MBM is significantly improved after surgery or SRS even in patients with advanced and uncontrolled systemic disease at the time of presentation, supporting an aggressive approach to MBM management.
更多
查看译文
关键词
BRAF inhibitors,MEK inhibitors,immunotherapy,malignant melanoma,systemic anticancer therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要